These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 22729439

  • 1. Second-trimester maternal serum markers and placenta accreta.
    Dreux S, Salomon LJ, Muller F, Goffinet F, Oury JF, ABA Study Group, Sentilhes L.
    Prenat Diagn; 2012 Oct; 32(10):1010-2. PubMed ID: 22729439
    [No Abstract] [Full Text] [Related]

  • 2. Second-trimester maternal serum screening for Down syndrome in Mainland China.
    Liao C, Huang Y, Li D, Song S, Yi C, Zhou J.
    Prenat Diagn; 2006 Dec; 26(13):1271-2. PubMed ID: 17139699
    [No Abstract] [Full Text] [Related]

  • 3. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
    Aitken DA, Wallace EM, Crossley JA, Swanston IA, van Pareren Y, van Maarle M, Groome NP, Macri JN, Connor JM.
    N Engl J Med; 1996 May 09; 334(19):1231-6. PubMed ID: 8606718
    [Abstract] [Full Text] [Related]

  • 4. First and second-trimester biochemical markers of chromosomal anomalies and their relationship to maternal haemoglobin levels.
    Cowans NJ, Spencer K.
    Prenat Diagn; 2005 Aug 09; 25(8):693-9. PubMed ID: 16050001
    [Abstract] [Full Text] [Related]

  • 5. Elevated maternal second-trimester serum alpha-fetoprotein as a risk factor for placental abruption.
    Tikkanen M, Hämäläinen E, Nuutila M, Paavonen J, Ylikorkala O, Hiilesmaa V.
    Prenat Diagn; 2007 Mar 09; 27(3):240-3. PubMed ID: 17238224
    [Abstract] [Full Text] [Related]

  • 6. Second-trimester maternal serum screening for Down syndrome in twin-to-twin transfusion syndrome.
    Sermondade N, Dreux S, Oury JF, Muller F.
    Prenat Diagn; 2009 Aug 09; 29(8):814-5. PubMed ID: 19418465
    [No Abstract] [Full Text] [Related]

  • 7. [Prenatal screening for major fetal defects by using of maternal serum markers].
    Bao P, Wu Y, Gu Q.
    Zhonghua Fu Chan Ke Za Zhi; 1997 Nov 09; 32(11):649-51. PubMed ID: 9639762
    [Abstract] [Full Text] [Related]

  • 8. Second Trimester Biochemical Markers as Possible Predictors of Pathological Placentation: A Retrospective Case-Control Study.
    Berezowsky A, Pardo J, Ben-Zion M, Wiznitzer A, Aviram A.
    Fetal Diagn Ther; 2019 Nov 09; 46(3):187-192. PubMed ID: 30726846
    [Abstract] [Full Text] [Related]

  • 9. [Analysis of Down syndrome screening by maternal serum detection in mid-pregnancy].
    Liu YH, Li LF, Wu YM.
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar 09; 30(3):532-4, 537. PubMed ID: 20335129
    [Abstract] [Full Text] [Related]

  • 10. Second trimester two-step trisomy 18 screening using maternal serum markers.
    Muller F, Sault C, Lemay C, Roussel-Mizon N, Forestier F, Frendo JL, ABA Collaborative Group.
    Prenat Diagn; 2002 Jul 09; 22(7):605-8. PubMed ID: 12124697
    [Abstract] [Full Text] [Related]

  • 11. [Relationship of adverse pregnancy outcomes and a high risk serum screen for Down syndrome in the second trimester].
    Hu XY, Bian XM, Jiang YL, Liu SY.
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jun 09; 47(6):427-30. PubMed ID: 22932108
    [Abstract] [Full Text] [Related]

  • 12. [Second trimester maternal serum screening for Down's syndrome in women of advanced maternal age: a multi-center prospective study].
    Qi QW, Jiang YL, Liu JT, Bian XM, Li Y, Lü SM, Zhu BS, Wang H, Xu ZF, Pan XY, Cai Y.
    Zhonghua Fu Chan Ke Za Zhi; 2008 Oct 09; 43(10):737-41. PubMed ID: 19087538
    [Abstract] [Full Text] [Related]

  • 13. Placenta accreta is associated with elevated maternal serum alpha-fetoprotein.
    Kupferminc MJ, Tamura RK, Wigton TR, Glassenberg R, Socol ML.
    Obstet Gynecol; 1993 Aug 09; 82(2):266-9. PubMed ID: 7687756
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of effect of analytical imprecision in maternal serum screening for Down's syndrome.
    Spencer K.
    Ann Clin Biochem; 2001 Jul 09; 38(Pt 4):413-4. PubMed ID: 11471889
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of second-trimester maternal serum free-beta-human chorionic gonadotropin and alpha-fetoprotein between normal singleton and twin pregnancies: a population-based study.
    Zheng MM, Hu YL, Zhang CY, Ru T, Liu QL, Xu BY, Chen QG, Xu ZF, Zhang Y, Zhong XL.
    Chin Med J (Engl); 2010 Mar 05; 123(5):555-8. PubMed ID: 20367980
    [Abstract] [Full Text] [Related]

  • 16. The variation of risk estimates through pregnancy in second trimester maternal serum screening for Down syndrome.
    Christiansen M, Høgdall EV, Larsen SO, Høgdall C.
    Prenat Diagn; 2002 May 05; 22(5):385-7. PubMed ID: 12001192
    [Abstract] [Full Text] [Related]

  • 17. Contingent triple-screening for Down syndrome in the second trimester: a feasibility study in Mainland Chinese population.
    Xie Z, Lu S, Li H.
    Prenat Diagn; 2010 Jan 05; 30(1):74-6. PubMed ID: 19967750
    [Abstract] [Full Text] [Related]

  • 18. Second trimester levels of pregnancy associated plasma protein-A in cases of trisomy 18.
    Spencer K, Crossley JA, Green K, Worthington DJ, Brownbill K, Aitken DA.
    Prenat Diagn; 1999 Dec 05; 19(12):1127-34. PubMed ID: 10590430
    [Abstract] [Full Text] [Related]

  • 19. [Trisomy 21 screening: value of ultrasound and serum markers in a combined approach].
    Senat MV, Rozenberg P, Bernard JP, Ville Y.
    J Gynecol Obstet Biol Reprod (Paris); 2001 Feb 05; 30(1):11-27. PubMed ID: 11240502
    [No Abstract] [Full Text] [Related]

  • 20. Maternal serum activin, inhibin, human chorionic gonadotrophin and alpha-fetoprotein as second trimester predictors of pre-eclampsia.
    Davidson EJ, Riley SC, Roberts SA, Shearing CH, Groome NP, Martin CW.
    BJOG; 2003 Jan 05; 110(1):46-52. PubMed ID: 12504935
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.